Related references
Note: Only part of the references are listed.Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York
Fatimah S. Dawood et al.
JAMA PEDIATRICS (2022)
Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2
Erika Molteni et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021
Megan Wallace et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Addressing Racial and Ethnic Disparities in COVID-19 Among School-Aged Children: Are We Doing Enough?
Arica White et al.
PREVENTING CHRONIC DISEASE (2021)
Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School — Marin County, California, May–June 2021
Tracy Lam-Hine et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Julia W. Gargano et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Sara E. Oliver et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)